News / Partnerships - August 2, 2022
The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) joined the 57 partner organisations that co-signed EURORDIS’ letter calling on the European Commission to take forward the conclusions of the conference for a European Action Plan on Rare Diseases. EUCOPE is a strong champion for a holistic… read more
News - July 28, 2022
On July 14, the European Commission formally published its proposal updating the BTC legislation. Under the Commission’s proposal, the two Directives (2002/98/EC, for blood and blood components and 2004/23/EC, for tissues and cells) will be rolled into one Regulation, the SoHO (Substances of Human Origin) Regulation…. read more
News / Partnerships - July 27, 2022
EUCOPE has been selected to join the Joint Industrial Cooperation Forum (JICF), a sub-group of the Health Emergency Preparedness and Response Advisory (HERA) Forum. The first meeting of the JICF took place on 13 July where EUCOPE, along with other industrial organizations and national representatives,… read more
EUCOPE Resources / News - July 19, 2022
Sounds of Science Podcast – Episode 7 Unmet Medical Needs (UMN): Towards a new understanding with a focus on underserved areas The topic of unmet medical needs (UMN) is quite high up on the agenda in European health policy these days. Recent literature has identified… read more
EUCOPE Resources / News - July 1, 2022
The objective of this survey is to capture the consequences of the Medical Devices Regulation (MDR) on innovative European companies, including those that have received significant government money. We expect that a contradiction could emerge between the massive investment done by the EU and Member… read more
News / Partnerships / Partnerships in Focus - June 30, 2022
At EUCOPE, our commitment is to lead and engage in partnerships spanning the entire medicine lifecycle to find actionable solutions that benefit our members, the patients they serve and healthcare systems overall. Through our Partnerships in Focus series, we’ll be highlighting different associates that we… read more
News / Press Releases - June 28, 2022
The European Confederation of Pharmaceuticals Entrepreneurs (EUCOPE) announced the joining of six (6) new members at its quarterly Members Meeting on June 22nd following Board approval. The new members joining EUCOPE network are: Amylyx Pharmaceuticals, Arnold&Porter, Bavarian Nordic, Laboratoire Cevidra and Urovant Sciences. During the… read more
Events & Meetings / News - June 24, 2022
The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) hosted a virtual roundtable on the future of rare diseases in Europe and the Czech Republic on Monday, 20 June 2022. With the Czech Republic holding the rotating presidency of the Council of the European Union from July… read more
Member Spotlight / News - June 24, 2022
Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In June, we spoke with Julien Patris, Head of Policy – International Markets at Alnylam Pharmaceuticals. Julien Patris is Country… read more
News / Press Releases - June 23, 2022
BRUSSELS & BOSTON – The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), the European trade body representing small and mid-sized innovative health technology companies, and the Massachusetts Biotechnology Council (MassBio), the association representing the premier global life sciences and healthcare hub, with 1,500+ members, have signed… read more
You are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Instagram. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information